Review of the Results of Eropen 700 in the Treatment of Patients with Erectile Dysfunction

Authors

  • Azimov Sardorbek Ilkhomovich Bukhara State Medical Institute

Keywords:

erectile dysfunction, impotence, Eropen 700, decreased libido, testosterone

Abstract

The article presents the results of studies conducted in patients with erectile dysfunction of various etiologies. In the course of the study in male patients of different age, who had sexual disorders, decreased libido, premature ejaculation, decreased orgasm, as well as qualitative and quantitative disorders in spermograms of various degrees, there were no side effects and complications after taking the drug Eropen 700.

References

Shodiev O’lmas Mustafoevich, Expression level of anti-apoptotic protein Bcl-2 in bladder papillomas(2022/8/13).Web of Scientist: International Scientific research Journal. № 3(8) P. 297-305

Azimov S.I. Effectiveness of universal urological questionnaire in screening of urological pathology in tuberculosis patients. ‘Uzbekistan doctorlar assotsiyatsiyasi’ scientific and practical journal No. 4, 2019 P.103-107

Azimov S.I. The role of universal urological questionnaire in the examination of urological pathology in patients with tuberculosis. Scientific report “Tibbiyotda yangi kun”, Spiritual and educational journal № 3 (31), 2020. С.238-241

Azimov S. I. Current international standards for monitoring lower urinary tract symptoms and sings of benign prostatic hyperplasia and tuberculosis patients. Journal of Natural Remedies Vol.22, №.1(2), (2021) pp.117-123

Azimov S.I. Possibilities of therapeutic and prophylactic tactics in benign prostatic hyperplasia in patients with tuberculosis. Tuberculosis and pulmonary diseases, Vol. 99, No. 7, 2021. С.26-30

Azimov S.I. Immunological status and tactics of treatment of non-specific urinary tract infection in tuberculosis patients. Problems of biology and medicine. - Samarkand, 2022. - № 4 (137). - С.12-17 (14.00.00; №19)

Azimov S.I. Clinical and immunological characteristics of urological diseases accompanied by pulmonary tuberculosis. Problems of biology and medicine. - Samarkand, 2022. - №4 (137). - С.211-214 (14.00.00; №19)

Azimov S. I. Immunological Description of the Study of Urological Diseases Accompanied by Pulmonary Tuberculosis. Medical and natural sciences. - 2022 - Volume 03, Issue 04. - P.247-250.

Azimov S. I. Immune Dysfunctions and Their Prevention During the Use of the Drug Canefron N in the Complex Treatment of Chronic Pyelonephritis. European Journal of Modern Medicine and Practice. - 2022 - Volume 02, Issue 05. - P.54-58.

Azimov S.I. Role of universal urological questionnaire in screening of urological pathology in tuberculosis patients. ‘Vestnik nauki i obrazovanie’. Russian impact factor:3,58 scientific and methodological journal. Moscow. no. 23(101). Part 2 2020. С.79-83

Azimov S. I. The Effectiveness of the Universal Urological Questionnaire in the Screening of Urological Pathology in patients with Tuberculosis. International Engineering journal for research and development (IEJRD) Vol.5, Speical Issue 9 (2020) №:-2349-0721 pp.1-3

Azimov S.I. The Effectiveness of the Universal Urological Questionnaire in the Screening of Urological Pathology in Patients with Tuberculosis // International Engineering journal for research and development (IEJRD) Vol.5, Special Issue 9 (2020) №:-2349-0721 pp. 1-3.

Azimov S.I., Khamdamov B.Z. Immune dysfunctions and their prevention during the use of the drug canefron n in the complex treatment of chronic pyelonephritis/ European journal of modern medicine and practice. Vol.2 No.5 (2022).- P.54-58/

Azimov S. I., Rashidov Z. R. The Role of the Universal Urological Questionnaire in the Screening of Urological Pathology in Patients with Tuberculosis // American Journal of Medicine and Medical Sciences, 2020 10(10), pp. 769-772

Downloads

Published

2024-06-19

How to Cite

Ilkhomovich, A. S. (2024). Review of the Results of Eropen 700 in the Treatment of Patients with Erectile Dysfunction. International Journal of Integrative and Modern Medicine, 2(6), 561–564. Retrieved from https://medicaljournals.eu/index.php/IJIMM/article/view/626